🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 2 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/11/2020 | 53,34 | 53,84 | 51,65 | 52,22 | -1,36% | 4,11% | 423.352 |
| 12/11/2020 | 51,98 | 53,86 | 51,78 | 52,94 | +1,45% | 4,00% | 402.674 |
| 11/11/2020 | 51,83 | 53,03 | 51,71 | 52,18 | +1,71% | 2,54% | 281.647 |
| 10/11/2020 | 51,00 | 52,49 | 50,66 | 51,30 | +0,57% | 3,60% | 985.845 |
| 09/11/2020 | 55,23 | 56,23 | 50,74 | 51,01 | -5,36% | 9,94% | 1.061.988 |
| 06/11/2020 | 54,79 | 55,34 | 52,36 | 53,90 | -1,87% | 5,43% | 403.796 |
| 05/11/2020 | 55,56 | 55,74 | 54,46 | 54,93 | +0,57% | 2,30% | 317.234 |
| 04/11/2020 | 54,40 | 57,24 | 54,34 | 54,62 | +1,44% | 5,33% | 442.588 |
| 03/11/2020 | 52,01 | 54,31 | 52,00 | 53,84 | +4,11% | 4,45% | 482.343 |
| 02/11/2020 | 52,15 | 53,57 | 50,75 | 51,72 | +0,55% | 5,42% | 469.839 |
| 30/10/2020 | 50,22 | 52,80 | 48,82 | 51,43 | -0,75% | 7,92% | 877.963 |
| 29/10/2020 | 52,78 | 53,60 | 50,16 | 51,82 | -1,60% | 6,52% | 731.930 |
| 28/10/2020 | 53,03 | 54,45 | 52,46 | 52,66 | -2,04% | 3,75% | 519.853 |
| 27/10/2020 | 53,15 | 53,90 | 52,60 | 53,76 | +1,46% | 2,44% | 552.073 |
| 26/10/2020 | 52,71 | 53,72 | 51,70 | 52,99 | -0,09% | 3,83% | 2.081.656 |
| 23/10/2020 | 55,47 | 55,50 | 52,40 | 53,04 | +0,33% | 5,59% | 1.122.421 |
| 22/10/2020 | 50,53 | 53,91 | 50,53 | 52,86 | +5,20% | 6,69% | 684.321 |
| 21/10/2020 | 54,90 | 55,53 | 49,94 | 50,25 | -9,21% | 10,17% | 1.321.674 |
| 20/10/2020 | 58,00 | 58,85 | 55,11 | 55,35 | -4,58% | 6,45% | 1.173.075 |
| 19/10/2020 | 60,85 | 61,73 | 57,40 | 58,00 | -4,45% | 7,13% | 413.895 |
| 16/10/2020 | 60,27 | 61,22 | 58,57 | 60,70 | +1,50% | 4,40% | 329.737 |
| 15/10/2020 | 61,77 | 62,25 | 59,26 | 59,81 | -4,14% | 4,83% | 441.466 |
| 14/10/2020 | 64,10 | 64,51 | 62,35 | 62,39 | -2,38% | 3,37% | 196.047 |
| 13/10/2020 | 63,72 | 64,89 | 63,09 | 63,91 | +0,29% | 2,83% | 296.074 |
| 12/10/2020 | 63,57 | 64,51 | 62,38 | 63,72 | +0,53% | 3,35% | 261.930 |
| 09/10/2020 | 65,50 | 65,88 | 63,18 | 63,39 | -2,34% | 4,12% | 361.637 |
| 08/10/2020 | 65,71 | 65,81 | 63,79 | 64,90 | -0,07% | 3,08% | 307.776 |
| 07/10/2020 | 63,25 | 65,22 | 63,25 | 64,95 | +2,86% | 3,11% | 309.539 |
| 06/10/2020 | 65,56 | 66,68 | 62,60 | 63,14 | +0,96% | 6,21% | 574.836 |
| 05/10/2020 | 61,03 | 63,20 | 60,56 | 62,55 | +3,20% | 4,33% | 464.069 |